Wednesday, July 8, 2026

Drug profile · INN

xenon xe-133

xenon xe-133 (XENON XE 133) is a diagnostic agent. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: inhalation, injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — xenon xe-133
US status
approved
Class
Route
INHALATION, INJECTION
Patents
1
Programs
1
Data quality
0.89

Quick answer

xenon xe-133 (XENON XE 133) is a diagnostic agent. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: inhalation, injection. Current US regulatory status: approved.

Key facts

INN xenon xe-133
Brand XENON XE 133
Mechanism Diagnostic agent
Route INHALATION, INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. 3-V Bioscience-2640 Phase 2 · Sagimet Biosciences · Metabolic Syndrome
  1. US 11622968

    Heterocyclic modulators of lipid synthesis

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is xenon xe-133?

xenon xe-133 (XENON XE 133) is a diagnostic agent. Associated with Sunshine Guojian Pharmaceutical (Shanghai) Co.,. Route of administration: inhalation, injection. Current US regulatory status: approved.

What is the brand name for xenon xe-133?

XENON XE 133 is a marketed brand name for xenon xe-133. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of xenon xe-133?

xenon xe-133 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.